These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5169959)

  • 1. [Thrombocytemia resulting in acute megakaryoblastosis].
    Frinovskaia IV; Anokhina IuV
    Ter Arkh; 1971 Nov; 43(11):112-4. PubMed ID: 5169959
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of circulating megakaryocytes in chronic myeloproliferative syndromes.
    Hanganu E; Iordăcheanu L; Popa G
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(3):377-8. PubMed ID: 6587496
    [No Abstract]   [Full Text] [Related]  

  • 3. Etiology of the myeloproliferative disorders: the role of thrombopoietin.
    Kaushansky K
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):6-9. PubMed ID: 12682875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute malignant megakaryocytosis associated with pancytopenia].
    Woessner S; Sans-Sabrafen J; Simo Camps E; Garcia san Miguel J; Rozman C
    Sangre (Barc); 1970; 15(1):89-97. PubMed ID: 5463616
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
    Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
    J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metamorphosis of chronic myeloproliferative diseases].
    Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute myelofibrosis and acute megakaryoblastic/megakaryocytic leukemia. A study on clinicopathologic correlations in a patient and reports of the literature].
    Hirano K; Takenaka T; Nakamine H; Oshiro I; Maeda J; Kishi T; Murakami S; Yokoya Y; Nishioka S; Yataka I
    Rinsho Ketsueki; 1984 Aug; 25(8):1290-8. PubMed ID: 6542604
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foot ischemia related to essential thrombocytemia and atherosclerosis.
    Legrand F; Fernex de Mongex A; Delrue M; Ghaffari P; Jaillette C; Yannoutsos A; Emmerich J; Priollet P
    J Med Vasc; 2021 May; 46(3):123-128. PubMed ID: 33990286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To treat or not to treat acute granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1968 Jul; 122(1):79-80. PubMed ID: 5241833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 12. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subarachnoid block in a patient with essential thrombocytemia.
    García-Ferreira J; Hernández-Palazón J; García-Candel A; Verdú-Martínez T
    Anesth Analg; 2005 Jul; 101(1):300. PubMed ID: 15976261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Megakaryopoiesis in chronic myeloproliferative disorders].
    Nagasawa T
    Rinsho Ketsueki; 1993 May; 34(5):551-6. PubMed ID: 8315826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombocythemia].
    Kraus W
    Z Gesamte Inn Med; 1970 Mar; 25(5):221-6. PubMed ID: 5535579
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
    Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
    Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood essential thrombocythaemia.
    Roy NB; Treacy M; Kench P
    Br J Haematol; 2005 Jun; 129(5):567. PubMed ID: 15916677
    [No Abstract]   [Full Text] [Related]  

  • 18. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
    Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masked thrombocythaemia.
    Monson JP; Bensted J; Clink H; Mayne S; Wells B; Spathis GS
    Br J Clin Pract; 1977 Dec; 31(12):222-3. PubMed ID: 564702
    [No Abstract]   [Full Text] [Related]  

  • 20. Early severe preeclampsia with marked platelet dysfunction in association with essential thrombocytemia: case report and discussion.
    Onisai M; Voican I; Ciorascu M; Popov V; Bumbea H; Gaman M; Filipescu A; Vladareanu R; Vladareanu AM
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):830-3. PubMed ID: 26196190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.